CORRESP Filing
Jin Medical International Ltd.
Date: Sept. 5, 2025 · CIK: 0001837821 · Accession: 0001213900-25-084742
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-288314
Letter
Jin Medical International Ltd.
No. 33 Lingxiang Road, Wujin District
Changzhou City, Jiangsu Province
People's Republic of China
September 5, 2025
VIA EDGAR
Securities and Exchange Commission
Division of Corporate Finance
100 F Street, NE
Washington, D.C. 20549
Attn: Ms. Jane Park
Re:
Jin Medical International Ltd. Registration Statement on Form F-3 File No. 333-288314
Ladies and Gentlemen:
Pursuant to Rule 461 of the General Rules and Regulations promulgated under the Securities Act of 1933, as amended, Jin Medical International Ltd. hereby requests the United States Securities and Exchange Commission take appropriate action to cause the above-referenced Registration Statement on Form F-3 to become effective on September 9, 2025, at 9:00 a.m. Eastern Time, or as soon thereafter as practicable.
Please feel free to direct any questions or comments concerning this request to our U.S. legal counsel, Ms. Huan Lou of McCarter & English, LLP by telephone at +1 (212)-609-6921 or via e-mail at hlou@mccarter.com .
Very truly yours,
For and on behalf of
Jin Medical International Ltd.
Show Raw Text
CORRESP 1 filename1.htm Jin Medical International Ltd. No. 33 Lingxiang Road, Wujin District Changzhou City, Jiangsu Province People's Republic of China September 5, 2025 VIA EDGAR Securities and Exchange Commission Division of Corporate Finance 100 F Street, NE Washington, D.C. 20549 Attn: Ms. Jane Park Re: Jin Medical International Ltd. Registration Statement on Form F-3 File No. 333-288314 Ladies and Gentlemen: Pursuant to Rule 461 of the General Rules and Regulations promulgated under the Securities Act of 1933, as amended, Jin Medical International Ltd. hereby requests the United States Securities and Exchange Commission take appropriate action to cause the above-referenced Registration Statement on Form F-3 to become effective on September 9, 2025, at 9:00 a.m. Eastern Time, or as soon thereafter as practicable. Please feel free to direct any questions or comments concerning this request to our U.S. legal counsel, Ms. Huan Lou of McCarter & English, LLP by telephone at +1 (212)-609-6921 or via e-mail at hlou@mccarter.com . Very truly yours, For and on behalf of Jin Medical International Ltd. /s/ Erqi Wang Name: Erqi Wang Title: Chief Executive Officer